C-Reactive Protein Is a Poor Marker of Baseline Inflammation in Prostate Cancer and Response to Radiotherapy or Androgen Ablation

Introduction C-reactive protein (CRP) is an acute-phase reactant used as a general marker for inflammation. Isolated levels have been associated with prostate cancer development, prostate-specific antigen (PSA), Gleason score, and treatment response. We seek to establish whether CRP levels reflect i...

Descripción completa

Detalles Bibliográficos
Autores principales: Jensen, Garrett L, Naziri, Jason, Hammonds, Kendall P, Jhavar, Sameer G, Swanson, Gregory
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Radiation Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8673689/
https://www.ncbi.nlm.nih.gov/pubmed/34926085
http://dx.doi.org/10.7759/cureus.19639

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8673689/
https://www.ncbi.nlm.nih.gov/pubmed/34926085
http://dx.doi.org/10.7759/cureus.19639

Ejemplares similares